TIMP-1 expression induced by IL-32 is mediated through activation of AP-1 signal pathway

International Immunopharmacology
Haixia XuXiaomou Peng

Abstract

Hepatic fibrosis is a necessarily stage from the progression of chronic liver diseases to cirrhosis, even hepatocellular carcinoma (HCC). Hepatic fibrosis is characterized by the progressive accumulation of extracellular matrix (ECM). The balance between ECM production and degradation is mediated by matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). TIMP-1 is an important regulator in the synthesis and degradation of ECM. IL-32, a multi-function cytokine, could induce IL-1β, IL-6, IL-8 and other cytokine expressions by activating AP-1, NF-κβ, p38MAPK signal pathways. IL-32 expression is increased in liver tissues of hepatic fibrosis. However, the role of IL-32 in the pathogenesis of liver fibrosis is not thoroughly clear. Recently, it is demonstrated that TIMP-1 expression is induced by the activation of AP-1 signal pathway. So we assayed the effect of IL-32 on TIMP-1 expression by LX-2 cells (one of HSCs cell lines) in the present study. We found that IL-32 could induce TIMP-1 expression by LX-2 cells at a dose-dependent manner. IL-32 could increase TIMP-1 promoter activity and induce TIMP-1 expression by activating AP-1 signal pathway. Moreover, the increase of TIMP-1 expression could promot...Continue Reading

References

Nov 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H YoshijiH Fukui
Feb 7, 2002·Journal of Hepatology·David CassimanTania Roskams
Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Morris Sherman, Andrew Klein
Oct 14, 2006·Annals of the Rheumatic Diseases·Charles A Dinarello, S-H Kim
May 9, 2007·Gastroenterology·Samuele De MinicisRobert F Schwabe
Feb 26, 2008·Proceedings of the National Academy of Sciences of the United States of America·Mihai G NeteaSoo-Hyun Kim
May 13, 2008·Gastroenterology·Scott L Friedman
Nov 6, 2008·Clinics in Liver Disease·Young-Suk Lim, W Ray Kim
Apr 24, 2009·The Journal of Biological Chemistry·Atsushi NishidaYoshihide Fujiyama
Mar 8, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alexander R MoschenHerbert Tilg
Jun 13, 2012·The Journal of Infection·Qihuan XuGang Li
Jan 13, 2015·The Journal of Biological Chemistry·Mehdi Ramezani-MoghadamLionel Hebbard

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Related Papers

Liver International : Official Journal of the International Association for the Study of the Liver
Eiji MatsumotoYasushi Shiratori
The International Journal of Biochemistry & Cell Biology
J P Iredale
© 2021 Meta ULC. All rights reserved